Faron moves ahead with “shock lung” drug
Finnish firm eyes first drug for acute respiratory distress syndrome.
X
Faron moves ahead with “shock lung” drug
https://pharmaphorum.com/news/faron-pushing-shock-lung-drug/
regulation
EU court blocks clinical data release, regulator appeals
EU court to rule on legal row.
FDA’s Duchenne drug approval greeted with joy, but remains controversial
FDA will require efficacy evidence.
Regulatory timelines in the Asia-Pacific
Snapshot of clinical trial application processes in the region.
Are European incentives speeding access in rare cancer treatments?
Examining the impact of support programmes for orphan treatments.
UK could quit EU drug regulation system – minister
Nothing has been ruled in or out, says George Freeman.
Brexit ‘an opportunity for UK pharma’
UK economy will be more dynamic, says IDEA’s Mike Rea.
FDA reveals plans for single cancer drug regulation centre
Scheme is part of US government Cancer Moonshot initiative
FDA fast-tracks review of Roche’s potential MS blockbuster
Regulator to make decision by year end.